atai Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 in Treatment-Resistant Depression - Quiver Quantitative

Submitted by Anonymous (not verified) on Thu, 10/16/2025 - 20:24

atai Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 in Treatment-Resistant Depression  Quiver Quantitative